The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,645,720 in first-year total cost, median $667,827.
Most frequent study sections
- Special Emphasis Panel[ZAI1 JKB-A (J2)]4
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL2
- OREGON HEALTH & SCIENCE UNIVERSITY1
- UNIVERSITY OF PENNSYLVANIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | CDRH3-independent B cell stimulation to selectively expand VRC01 lineages from a fully humanized immunoglobulin repertoire1R01AI124378-01 | CHACKERIAN, BRYCE CLINGWOOD, DANIEL | MASSACHUSETTS GENERAL HOSPITAL, MA | $475,680 | ZAI1 |
| 2016 | Efficacy of Strain 68-1 RhCMV Vectors Expressing 5' Leader Polypeptides1R01AI124370-01 | HANSEN, SCOTT G | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $882,566 | ZAI1 |
| 2016 | Nucleoside modified mRNA based HIV vaccine1R01AI124429-01 | WEISSMAN, DREW | UNIVERSITY OF PENNSYLVANIA, PA | $859,974 | ZAI1 |
| 2016 | Immune protection against HIV by induction of CD4+CTLs.1R01AI124418-01 | PILLAI, SHIV SUBRAMANIAM | MASSACHUSETTS GENERAL HOSPITAL, MA | $427,500 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.